# Injured epithelial cell states impact kidney allograft survival after T-cell-mediated rejection

**Authors:** Anna Maria Pfefferkorn, Lorenz Jahn, Patrick T. Gauthier, Vera Anna Kulow, Johannes Roeles, Niklas Müller-Bötticher, Louisa M. S. Gerhardt, Janna Leiz, Sadia Sarfraz, Izabela Plumbom, Robert Greite, Svjetlana Lovric, Jaba Gamrekelashvili, Florian Limbourg, Jessica Schmitz, Jan Hinrich Bräsen, Irina Scheffner, Igor M. Sauer, Felix Aigner, Janine Altmüller, Thomas Conrad, Wilfried Gwinner, Naveed Ishaque, Michael Fähling, Kai M. Schmidt-Ott, Philip F. Halloran, Muhammad Imtiaz Ashraf, Christian Hinze

PMC · DOI: 10.1038/s41467-026-68397-1 · 2026-01-28

## TL;DR

The study finds that injured epithelial cells in the kidney after T-cell rejection affect transplant survival, highlighting a new target for improving outcomes.

## Contribution

The study identifies specific injured epithelial cell states in kidney transplants that correlate with poor outcomes after T-cell-mediated rejection.

## Key findings

- Injured epithelial cell states in mouse kidney allografts are induced by T-cell-mediated rejection.
- Severely injured epithelial states in human samples correlate with transplant survival and persist after rejection resolution.
- Spatial transcriptomics reveals heterogeneous localization and interactions of injured epithelial cells with immune cells.

## Abstract

T-cell–mediated rejection (TCMR) remains a major cause of kidney transplant failure, despite being considered treatable. Its impact reflects a limited understanding of the underlying molecular mechanisms and their clinical consequences. To address this, we induced acute TCMR in mouse kidney transplants and profiled molecular changes using single-nucleus RNA sequencing (snRNA-seq), spatial transcriptomics and immunofluorescence. Results were compared with human snRNA-seq data from TCMR and stable allografts, as well as single-cell deconvolution analysis of bulk transcriptomic data from kidney transplant biopsies. Here we show that TCMR induces injured epithelial cell states in mouse kidney allografts, particularly in proximal tubules and thick ascending limbs. Spatial transcriptomics of these injured epithelial states demonstrated heterogeneous localization, interactions with immune cells and cellular microenvironments. Cross-species analysis confirmed similar severely injured epithelial states in human samples, whose abundances correlated with transplant survival and persisted despite TCMR resolution. Collectively, our results identify epithelial injury cell states as a determinant of outcome after TCMR.

T-cell–mediated rejection (TCMR) remains a major cause of kidney transplant failure with incompletely understood mechanisms. Here the authors use single-nucleus RNA sequencing, spatial transcriptomics and immunofluorescence to show that injured kidney epithelial cell states associate with poor transplant outcomes after T-cell–mediated rejection.

## Linked entities

- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Ifna (interferon alpha complex region) [NCBI Gene 111654] {aka Ifa, Ifa8}, ACTA2 (actin alpha 2, smooth muscle) [NCBI Gene 59] {aka ACTSA, SMDYS}, SPP1 (secreted phosphoprotein 1) [NCBI Gene 6696] {aka BNSP, BSPI, ETA-1, OPN}, KLF7 (KLF transcription factor 7) [NCBI Gene 8609] {aka UKLF}, MAP3K13 (mitogen-activated protein kinase kinase kinase 13) [NCBI Gene 9175] {aka LZK, MEKK13, MLK}, Il2 (interleukin 2) [NCBI Gene 16183] {aka Il-2}, FOXC1 (forkhead box C1) [NCBI Gene 2296] {aka ARA, ASGD3, FKHL7, FREAC-3, FREAC3, IGDA}, MYO5B (myosin VB) [NCBI Gene 4645] {aka DIAR2, MVID1, PFIC10}, HAVCR1 (hepatitis A virus cellular receptor 1) [NCBI Gene 26762] {aka CD365, HAVCR, HAVCR-1, KIM-1, KIM1, TIM}, DCDC2 (doublecortin domain containing 2) [NCBI Gene 51473] {aka DCDC2A, DFNB66, NPHP19, NSC, RU2, RU2S}, PROS1 (protein S) [NCBI Gene 5627] {aka PROS, PS21, PS22, PS23, PS24, PS25}, ATF3 (activating transcription factor 3) [NCBI Gene 467], ACSM3 (acyl-CoA synthetase medium chain family member 3) [NCBI Gene 6296] {aka SA, SAH}, Lcn2 (lipocalin 2) [NCBI Gene 16819] {aka 24p3, NRL, Sip24}, PDGFB (platelet derived growth factor subunit B) [NCBI Gene 5155] {aka IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis}, Cxcl10 (C-X-C motif chemokine ligand 10) [NCBI Gene 15945] {aka C7, CRG-2, INP10, IP-10, IP10, Ifi10}, SOCS3 (suppressor of cytokine signaling 3) [NCBI Gene 9021] {aka ATOD4, CIS3, Cish3, SOCS-3, SSI-3, SSI3}, Ccl5 (C-C motif chemokine ligand 5) [NCBI Gene 20304] {aka MuRantes, RANTES, SISd, Scya5, TCP228}, WNT5A (Wnt family member 5A) [NCBI Gene 7474] {aka hWNT5A}, H2-Eb1 (histocompatibility 2, class II antigen E beta) [NCBI Gene 14969] {aka Eb, H-2Eb, H2Eb, Ia-4, Ia4}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, UPP1 (uridine phosphorylase 1) [NCBI Gene 7378] {aka UDRPASE, UP, UPASE, UPP}, Gem (GTP binding protein overexpressed in skeletal muscle) [NCBI Gene 14579], STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772] {aka CANDF7, IMD31A, IMD31B, IMD31C, ISGF-3, STAT91}, VCAM1 (vascular cell adhesion molecule 1) [NCBI Gene 7412] {aka CD106, INCAM-100}, H2-Q6 (histocompatibility 2, Q region locus 6) [NCBI Gene 110557] {aka 0610037M15Rik, H-2Q6, H2-K1, Qa-6, Qa6}, STAT2 (signal transducer and activator of transcription 2) [NCBI Gene 6773] {aka IMD44, ISGF-3, P113, PTORCH3, STAT113}, TPM1 (tropomyosin 1) [NCBI Gene 7168] {aka C15orf13, CMD1Y, CMH3, HEL-S-265, HTM-alpha, LVNC9}, EDN1 (endothelin 1) [NCBI Gene 1906] {aka ARCND3, ET1, HDLCQ7, PPET1, QME}, JAG1 (jagged canonical Notch ligand 1) [NCBI Gene 182] {aka AGS, AGS1, AHD, AWS, CD339, CMT2HH}, PARP14 (poly(ADP-ribose) polymerase family member 14) [NCBI Gene 54625] {aka ARTD8, BAL2, PARP-14, pART8}, B2M (beta-2-microglobulin) [NCBI Gene 567] {aka AMYLD6, IMD43, MHC1D4}, SDC1 (syndecan 1) [NCBI Gene 6382] {aka CD138, SDC, SYND1, syndecan}, ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383] {aka BB2, CD54, P3.58}, MAP3K1 (mitogen-activated protein kinase kinase kinase 1) [NCBI Gene 4214] {aka MAPKKK1, MEKK, MEKK 1, MEKK1, SRXY6}, IRF1 (interferon regulatory factor 1) [NCBI Gene 3659] {aka IMD117, IRF-1, MAR}, FSTL1 (follistatin like 1) [NCBI Gene 11167] {aka FRP, FSL1, OCC-1, OCC1, tsc36}, ITGB1 (integrin subunit beta 1) [NCBI Gene 3688] {aka CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA}, CD47 (CD47 molecule) [NCBI Gene 961] {aka IAP, MER6, OA3}, FLNA (filamin A) [NCBI Gene 2316] {aka ABP-280, ABPX, CSBS, CVD1, FGS2, FLN}, Cxcl9 (C-X-C motif chemokine ligand 9) [NCBI Gene 17329] {aka CMK, Mig, MuMIG, Scyb9, crg-10}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, ANXA3 (annexin A3) [NCBI Gene 306] {aka ANX3}, GBP2 (guanylate binding protein 2) [NCBI Gene 2634], SPARC (secreted protein acidic and cysteine rich) [NCBI Gene 6678] {aka BM-40, OI17, ON, ONT}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, SERPINA10 (serpin family A member 10) [NCBI Gene 51156] {aka PZI, ZPI}, H2-Q7 (histocompatibility 2, Q region locus 7) [NCBI Gene 15018] {aka H-2Q7, Ped, Q9, Qa-2, Qa-7, Qa7}, Havcr1 (hepatitis A virus cellular receptor 1) [NCBI Gene 171283] {aka KIM-1, TIM-1, Tim1, Timd1}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, CEBPD (CCAAT enhancer binding protein delta) [NCBI Gene 1052] {aka C/EBP-delta, CELF, CRP3, NF-IL6-beta}, XAF1 (XIAP associated factor 1) [NCBI Gene 54739] {aka BIRC4BP, HSXIAPAF1, XIAPAF1}, SLC12A1 (solute carrier family 12 member 1) [NCBI Gene 6557] {aka BSC, BSC-1, BSC1, CCC2, NKCC2}, CD74 (CD74 molecule) [NCBI Gene 972] {aka CLIP, DHLAG, HLADG, II, Ia-GAMMA, p33}, TNFAIP3 (TNF alpha induced protein 3) [NCBI Gene 7128] {aka A20, AIFBL1, AISBL, OTUD7C, TNFA1P2}, CRYAB (crystallin alpha B) [NCBI Gene 1410] {aka CMD1II, CRYA2, CTPP2, CTRCT16, HEL-S-101, HSPB5}, CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}
- **Diseases:** AKI (MESH:D058186), interstitial (MESH:D065167), nephron loss (MESH:D007683), kidney transplant failure (MESH:D051437), PT Injury m4 (MESH:D015479), epithelial injury (MESH:D009375), TCMR (MESH:D016399), UMAP (MESH:C567162), bleeding (MESH:D006470), cytotoxicity (MESH:D064420), alloimmune injury (MESH:C536394), edema (MESH:D004487), hypoxia (MESH:D000860), TAL Injury (MESH:D000094625), Injury (MESH:D014947), ischemia (MESH:D007511), graft dysfunction (MESH:D055031), arteritis (MESH:D001167), CKD (MESH:D051436), reperfusion injury (MESH:D015427), inflammation (MESH:D007249), kidney (MESH:D007674), PT (MESH:D007673)
- **Chemicals:** lipid (MESH:D008055), SDS (MESH:D012967), periodic acid (MESH:D010504), DAPI (MESH:C007293), A31572RRID (-), TBS-T (MESH:C027647), Creatinine (MESH:D003404), TBS (MESH:D013725), xylene (MESH:D014992), citric acid (MESH:D019343), paraformaldehyde (MESH:C003043), ethanol (MESH:D000431), glycerol (MESH:D005990), T (MESH:D014316), Urea (MESH:D014508), sucrose (MESH:D013395), steroid (MESH:D013256), PBS (MESH:D007854), Paraffin (MESH:D010232), 2-Mercaptoethanol (MESH:D008623), water (MESH:D014867), isoflurane (MESH:D007530)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** BALB/c — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0184), m1 — Mus musculus (Mouse), Mouse insulinoma, Transformed cell line (CVCL_4372), /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12852170/full.md

---
Source: https://tomesphere.com/paper/PMC12852170